| Product ID |
Product Name |
CAS# |
Purity |
| Y1344401 |
Hydrofurimazine |
2179052-10-7 |
98% |
| Y3307460 |
Msr-Ratio |
2290635-22-0 |
99% |
| Y1344115 |
HKSOX-1 |
1786411-17-3 |
98% |
| Y1247354 |
Lipid 5 |
2089251-33-0 |
98% |
| Y3108391 |
WSF1-IN-1 |
2379577-82-7 |
99% |
| Y1243019 |
Desmorpholinyl Quizartinib-PEG2-COOH |
2292116-14-2 |
95% |
| Y1251678 |
CE3F4 analog 1 |
2141967-43-1 |
99% |
| Y1247455 |
HKOCl-3 |
2031170-80-4 |
98% |
| Y3105181 |
Methyl 2,3-O-Isopropylidene-ß-L-ribofuranoside |
20672-63-3 |
96% |
| Y1341706 |
Pomalidomide-PEG3-azide |
2267306-15-8 |
98% |
| Y1247484 |
HKPerox-1 |
2240163-05-5 |
99% |
| Y1243020 |
HKOCl-4m |
2031170-88-2 |
98% |
| Y3108384 |
VEGFR-2-IN-6 |
444731-47-9 |
95% |
| Y1247391 |
BDP-13176 |
2290660-61-4 |
99% |
| Y3295467 |
SHP2-IN-6 hydrochloride |
2169223-49-6 |
98% |
| Y1247421 |
NF- activator 1 |
2387524-59-4 |
98% |
| Y1247355 |
Thalidomide-NH-PEG2-COOH |
2412056-45-0 |
98% |
| Y3102399 |
ARV-471 |
2229711-68-4 |
98% |
| Y3110189 |
Cl-NQTrp |
185351-23-9 |
98% |
| Y1247356 |
Pseudocoptisine chloride |
30044-78-1 |
99% |
| Y3110195 |
(R)-BRD3731 |
2056262-08-7 |
98% |
| Y3310799 |
(R)-Posenacaftor sodium |
2095064-09-6 |
98.96% |
| Y3305352 |
Angstrom6 |
220334-14-5 |
99% |
| Y1243022 |
HS271 |
2410393-15-4 |
99% |
| Y1335674 |
Pomalidomide-PEG2-azide |
2267306-14-7 |
98% |
| Y1341635 |
(S,R,S)-AHPC-C6-NH2 |
2306389-03-5 |
98% |
| Y1256246 |
Orexin receptor antagonist 3 |
1293282-55-9 |
99% |
| Y1256202 |
VU0453595 |
1432436-13-9 |
99% |
| Y1256102 |
(3S,4S)-ethyl4-aminotetrahydro-2H-pyran-3-carboxylate |
1398937-57-9 |
95% |
| Y1260468 |
Thalidomide-NH-CH2-COOH |
927670-97-1 |
98% |
| Y3110204 |
Pactimibe sulfate |
608510-47-0 |
98% |
| Y1260469 |
LEO 39652 |
1445656-91-6 |
99% |
| Y3190232 |
PD-1/PD-L1-IN-8 |
2230911-59-6 |
98% |
| Y1260510 |
Thalidomide-NH-PEG4-COOH |
2412056-48-3 |
97% |
| Y1251815 |
AMPA receptor modulator-2 |
2034181-36-5 |
99% |
| Y1251816 |
CFTR corrector 6 |
2226970-01-8 |
99% |
| Y1256103 |
MPT0G211 |
2151853-97-1 |
99% |
| Y1256203 |
XY028-140 |
2229974-83-6 |
98% |
| Y1256089 |
ASK120067 |
1934259-00-3 |
98% |
| Y1256104 |
Rezivertinib |
1835667-12-3 |
99% |
| Y3296005 |
IACS-8803 disodium |
2243079-36-7 |
98% |
| Y3298147 |
(R)-Funapide |
1259933-15-7 |
98% |
| Y1260536 |
(2R,5S)-Ritlecitinib |
1792180-79-0 |
98% |
| Y1251817 |
Integrin modulator 1 |
2023788-32-9 |
99% |
| Y1256091 |
Avatrombopag hydrochloride |
570403-17-7 |
98% |
| Y1256092 |
TLR7 agonist 3 |
1229024-78-5 |
98% |
| Y3289239 |
CD73-IN-4 |
2216764-29-1 |
99% |
| Y3314997 |
PF-06426779 |
1817628-40-2 |
99.47% |
| Y3289790 |
CBP/p300-IN-8 |
2304416-91-7 |
99% |
| Y3102599 |
RMC-0331 |
2488788-52-7 |
98% |
| Y1256105 |
BCL6-IN-4 |
2253879-65-9 |
98% |
| Y3101455 |
Purfalcamine |
1038620-68-6 |
99% |
| Y1256164 |
AZ506 |
2043321-54-4 |
99% |
| Y3101607 |
(S)-PI3Ka-IN-4 |
2322293-84-3 |
99% |
| Y1256165 |
F13714 fumarate |
208109-39-1 |
98% |
| Y3111984 |
Acivicin hydrochloride |
161922-40-3 |
99% |
| Y3290731 |
BI-6901 |
2040401-92-9 |
99% |
| Y1256177 |
Tau tracer 2 |
2173361-80-1 |
99% |
| Y1232779 |
AT-511 |
1998705-64-8 |
99% |
| Y3295126 |
Tunicamycin V |
66054-36-2 |
95% |
| Y1232701 |
Necroptosis-IN-1 |
1391980-92-9 |
98% |
| Y1232711 |
(E/Z)-E64FC26 |
2285446-67-3 |
99% |
| Y1335260 |
MC-Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH |
1599440-25-1 |
98% |
| Y3293078 |
Fmoc-D-Val-D-Cit-PAB |
1350456-69-7 |
98% |
| Y3286423 |
Ascr#18 |
1355681-10-5 |
98% |
| Y1343987 |
PF-00835231 |
870153-29-0 |
98% |
| Y3288947 |
Ac-FLTD-CMK |
2376255-48-8 |
99% |
| Y3112832 |
Fmoc-Gly-Gly-Phe-OH |
160036-44-2 |
98% |
| Y1232722 |
Sisunatovir hydrochloride |
1903763-83-6 |
98% |
| Y3112797 |
Enfumafungin |
260979-95-1 |
95%+ |
| Y1232724 |
MCC7840 sodium |
2380032-29-9 |
98% |
| Y3296724 |
NHC-diphosphate |
39023-73-9 |
98% |
| Y3291631 |
EST73502 hydrochloride |
2535970-65-9 |
99% |
| Y3294673 |
(R,R)-CXCR2-IN-2 |
1838123-22-0 |
99% |
| Y1232712 |
Sisunatovir |
1903763-82-5 |
98% |
| Y3291328 |
Aplaviroc hydrochloride |
461023-63-2 |
99% |
| Y1232748 |
Senaparib |
1401682-78-7 |
99% |
| Y1232725 |
BVDV-IN-1 |
345651-04-9 |
98% |
| Y3104954 |
(1-(5-fluoropyrimidin-2-yl)pyrrolidin-2-yl)methanol |
1420802-64-7 |
98% |
| Y1232703 |
1-(tert-Butyl )-3,5-dichlorobenzene |
1369899-62-6 |
97% |
| Y3268770 |
tert-Butyl 4-(aminomethyl)isoindoline-2-carboxylate |
1394954-74-5 |
95% |
| Y3296440 |
2-Amino-2-(1H-imidazol-5-yl)acetic acid |
13726-60-8 |
97% |
| Y3264021 |
tert-Butyl3-(hydroxymethyl)-3-methylmorpholine-4-carboxylate |
1374654-00-8 |
95% |
| Y3263939 |
3-Ethynyl-1H-indazole |
1383705-71-2 |
95% |
| Y3308804 |
1-(2,4-dinitrophenyl)-1H-1,2,3-benzotriazole |
13417-39-5 |
98% |
| Y3105196 |
3-bromo-1-(difluoromethyl)pyridin-2(1H)-one |
1263179-33-4 |
95% |
| Y3105200 |
3-Chloro-5-hydroxyisonicotinaldehyde |
1256791-44-2 |
95% |
| Y1232782 |
9-(4-chloro-6-phenyl-1,3,5-triazin-2-yl)-9H-carbazole |
1268244-56-9 |
97% |
| Y1232797 |
(5,6,7,8-Tetrahydroimidazo[1,2-a]pyridin-6-yl)methanol |
1256546-79-8 |
95% |
| Y3258897 |
2-ethylimidazo[1,2-a]pyridine-3-carboxylicacid |
1266866-71-0 |
95% |
| Y1232736 |
2,4-Diiodobromobenzene |
126063-04-5 |
98% |
| Y3269554 |
3-Fluoro-2-(trifluoromethyl)isonicotinaldehyde |
1227574-90-4 |
95% |
| Y1232857 |
6-Bromo-1-methyl-1H-indazole-4-carbonitrile |
1245465-10-4 |
95% |
| Y3315789 |
isobutyl(2,3,5-trifluoro-4-(4-oxo-3,4-dihydropyridin-1(2H)-yl)phenyl)carbamate |
1239515-40-2 |
97% |
| Y1336761 |
6-Chloropyridine-2,5-dicarboxylicacid |
1251953-02-2 |
98% |
| Y3290320 |
5-Amino-6-chloropicolinaldehyde |
1211591-39-7 |
95% |
| Y3197564 |
(3-Fluoro-2-(trifluoromethyl)pyridin-4-yl)methanol |
1227600-70-5 |
95% |
| Y3109254 |
1-(Tetrahydro-2H-pyran-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethyl)-1H-pyrazole |
1192187-75-9 |
98% |
| Y3197566 |
Methyl4-(isoxazol-5-yl)benzoate |
1196059-61-6 |
95% |
| Y3315920 |
Ethyl7-bromo-1-(2-morpholinoethyl)-3-(3-(naphthalen-1-yloxy)propyl)-1H-indole-2-carboxylate |
1073493-89-6 |
97% |